WHO ICTRP trial
The effect of hibiscus flower extract on blood pressure.
IRCT20250603066044N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20250603066044N1 |
|---|---|
| Public title | The effect of hibiscus flower extract on blood pressure. |
| Scientific title | Evaluation the effect of Althaea officinalis extract oral solution on blood pressure levels in patients with high blood pressure (HTN): A randomized double blind clinical trial |
| Primary sponsor | Ahvaz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Essential (primary) hypertension. Essential (primary) hypertension |
| Interventions | Intervention 1: Intervention group: Intervention group: In addition to antihypertensive medications, an oral solution of hibiscus extract prepared by Zarband Pharmaceutical Company will be administered twice daily for 2 weeks, with each… |
| Registration date | Jul 13, 2025 |
| Target size | 70 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: